Abstract
On the basis of different evidences, androstadienone, a steroid compound produced in the armpit, has been proposed as a human pheromone, although its physiological levels appear too low to induce a response under experimental conditions. For this reason, the majority of researchers in this area puts into question the “legitimacy” of androstadienone, and prefers to consider the axillary extracts in its entirety, like a sort of “medicinal tea”, the components of which still remain to be identified, but that taken together may induce a response, or function as a carrier of other active substances. Another option is that androstadienone acts with varying degrees of potency and, at lower concentrations, according to the context and to specific behavioral situations.
The aim of this paper is to review all relevant data regarding androstadienone, in order to ascertain whether it may be considered a physiological pheromone and, as such, a possible target of future modulators of some human behaviors.
Keywords: Pheromones, humans, androstadienone, hormones, behaviors, mood, emotions, axillary organ, Pheromone Receptors, steroidal secretions
Current Medicinal Chemistry
Title: Is Androstadienone a Putative Human Pheromone?
Volume: 18 Issue: 8
Author(s): D. Marazziti, P. Torri, S. Baroni, M. Catena Dell'Osso, G. Consoli and V. Boncinelli
Affiliation:
Keywords: Pheromones, humans, androstadienone, hormones, behaviors, mood, emotions, axillary organ, Pheromone Receptors, steroidal secretions
Abstract: On the basis of different evidences, androstadienone, a steroid compound produced in the armpit, has been proposed as a human pheromone, although its physiological levels appear too low to induce a response under experimental conditions. For this reason, the majority of researchers in this area puts into question the “legitimacy” of androstadienone, and prefers to consider the axillary extracts in its entirety, like a sort of “medicinal tea”, the components of which still remain to be identified, but that taken together may induce a response, or function as a carrier of other active substances. Another option is that androstadienone acts with varying degrees of potency and, at lower concentrations, according to the context and to specific behavioral situations.
The aim of this paper is to review all relevant data regarding androstadienone, in order to ascertain whether it may be considered a physiological pheromone and, as such, a possible target of future modulators of some human behaviors.
Export Options
About this article
Cite this article as:
Marazziti D., Torri P., Baroni S., Catena Dell'Osso M., Consoli G. and Boncinelli V., Is Androstadienone a Putative Human Pheromone?, Current Medicinal Chemistry 2011; 18 (8) . https://dx.doi.org/10.2174/092986711795029654
DOI https://dx.doi.org/10.2174/092986711795029654 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Levomilnacipran in the Management of Major Depressive Disorder: A Comprehensive Review
Current Neuropharmacology The Skeletal Effects of Gonadotropin-Releasing Hormone Antagonists: A Concise Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Inflammatory Aspects of Depression
Inflammation & Allergy - Drug Targets (Discontinued) Steroid Resistance in Severe Asthma: Current Mechanisms and Future Treatment
Current Pharmaceutical Design Does Parkinson’s Disease and Type-2 Diabetes Mellitus Present Common Pathophysiological Mechanisms and Treatments?
CNS & Neurological Disorders - Drug Targets Effect of Antenatal Steroids on Haemodynamics in the Normally Grown and Growth Restricted Fetus
Current Pediatric Reviews Interventions Against Sarcopenia in Older Persons
Current Pharmaceutical Design Targeting the Fibroblast Growth Factor Receptors for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Neuromodulation of Hippocampal Synaptic Plasticity, Learning, and Memory by Noradrenaline
Central Nervous System Agents in Medicinal Chemistry Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants
Endocrine, Metabolic & Immune Disorders - Drug Targets Sympathetic Overactivity in Hypertension and Cardiovascular Disease
Current Vascular Pharmacology Hypocretin Antagonists in Insomnia Treatment and Beyond
Current Pharmaceutical Design Genetics of Serotonin Receptors and Depression: State of the Art
Current Drug Targets Regulators of the G1 Phase of the Cell Cycle and Neurogenesis
Central Nervous System Agents in Medicinal Chemistry Metformin and Energy Metabolism in Breast Cancer: From Insulin Physiology to Tumour-initiating Stem Cells
Current Molecular Medicine Premature Adrenarche and its Association with Cardiovascular Risk in Females
Current Pharmaceutical Design Genetics of Obesity: What have we Learned?
Current Genomics Pathophysiology of Blood-Brain Barrier in Brain Injury in Cold and Hot Environments: Novel Drug Targets for Neuroprotection
CNS & Neurological Disorders - Drug Targets Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic Review
Current Neuropharmacology Sensory-Motor Integration in the Medial Medulla
Current Neuropharmacology